pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation
- PMID: 10992515
 - PMCID: PMC101567
 - DOI: 10.1128/IAI.68.10.6027-6033.2000
 
pMGA phenotypic variation in Mycoplasma gallisepticum occurs in vivo and is mediated by trinucleotide repeat length variation
Abstract
Chickens were infected with a pathogenic strain of Mycoplasma gallisepticum, and the expression of pMGA, the major surface protein, was inferred by examination of colonies from ex vivo cells. Within 2 days postinfection, 40% of cells had ceased the expression of the original pMGA surface protein (pMGA1.1), and by day 6, the majority of recovered cells were in this category. The switch in pMGA phenotype which had occurred in vivo was reversible, since most colonies produced from ex vivo progenitors exhibited frequent pMGA1. 1(+) sectors. After prolonged in vivo habitation, increasing proportions of recovered cells gave rise to variant pMGA colonies which had switched from the expression of pMGA1.1 to another gene, pMGA1.2, concomitant with the acquisition of a (GAA)(12) motif 5' to its promoter. Collectively, the results suggest that changes in M. gallisepticum pMGA gene expression in vivo are normal, common, and possibly obligate events for successful colonization of the host. Surprisingly, the initial cessation of pMGA1.1 expression occurred in the absence of detectable pMGA antibodies and seemed to precede the adaptive immune response.
Figures
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                
              
              
              
              
                
                
                References
- 
    
- Abu-Zahr M N, Butler M. Growth, cytopathogenicity and morphology of Mycoplasma gallisepticum and M. gallinarum in tracheal explants. J Comp Pathol. 1976;86:455–463. - PubMed
 
 - 
    
- Baseggio N, Glew M D, Markham P F, Whithear K G, Browning G F. Size and genomic location of the pMGA multigene family of Mycoplasma gallisepticum. Microbiology. 1996;142:1429–1435. - PubMed
 
 - 
    
- Bencina D, Kleven S H, Elfaki M G, Snoj A, Dove P, Dorrer D, Russ I. Variable expression of epitopes on the surface of Mycoplasma gallisepticum demonstrated with monoclonal antibodies. Avian Pathol. 1994;23:19–36. - PubMed
 
 - 
    
- Bordier C. Phase separation of integral membrane proteins in Triton-X114 solution. J Biol Chem. 1981;256:1604–1607. - PubMed
 
 - 
    
- Droesse M, Tangen G, Gummelt I, Kirchhoff H, Washburn L R, Rosengarten R. Major membrane proteins and lipoproteins as highly variable immunogenic surface components and strain-specific antigenic markers of Mycoplasma arthritidis. Microbiology. 1995;141:3207–3219. - PubMed
 
 
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
